Mammalian antimicrobial proteins and peptides: overview on the RNase A superfamily members involved in innate host defence.
暂无分享,去创建一个
[1] Jeffrey I. Gordon,et al. Angiogenins: a new class of microbicidal proteins involved in innate immunity , 2003, Nature Immunology.
[2] G. J. Swaminathan,et al. Mapping the Ribonucleolytic Active Site of Eosinophil-derived Neurotoxin (EDN) , 2001, The Journal of Biological Chemistry.
[3] J. Gabay,et al. Ubiquitous natural antibiotics. , 1994, Science.
[4] R. Larson,et al. Specific mode of interaction between components of model pulmonary surfactants using computer simulations. , 2002, Journal of molecular biology.
[5] Francis C. Neuhaus,et al. A Continuum of Anionic Charge: Structures and Functions of d-Alanyl-Teichoic Acids in Gram-Positive Bacteria , 2003, Microbiology and Molecular Biology Reviews.
[6] E. Hahn,et al. Secretion and tissue content of eosinophil cationic protein in Crohn's disease. , 2000, Journal of clinical gastroenterology.
[7] C. Deber,et al. Anionic phospholipids modulate peptide insertion into membranes. , 1997, Biochemistry.
[8] R. Hancock,et al. Cationic peptides: effectors in innate immunity and novel antimicrobials. , 2001, The Lancet. Infectious diseases.
[9] W. Fischer,et al. Effect of lipoteichoic acid on thermotropic membrane properties , 1997, Journal of bacteriology.
[10] Venge,et al. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[11] A. A. Bodegraven,et al. Serum Eosinophil Cationic Protein in Active and Quiescent Ulcerative Colitis , 2000 .
[12] J. Zhang,et al. Sequence variation at two eosinophil-associated ribonuclease loci in humans. , 2000, Genetics.
[13] G. Gleich. Mechanisms of eosinophil-associated inflammation. , 2000, The Journal of allergy and clinical immunology.
[14] E. Boix,et al. The contribution of noncatalytic phosphate-binding subsites to the mechanism of bovine pancreatic ribonuclease A , 1998, Cellular and Molecular Life Sciences CMLS.
[15] Jianzhi Zhang,et al. Human RNase 7: a new cationic ribonuclease of the RNase A superfamily. , 2003, Nucleic acids research.
[16] R. Hancock,et al. Cationic host defense (antimicrobial) peptides. , 2006, Current opinion in immunology.
[17] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.
[18] G. Gleich,et al. Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization. , 2003, The Journal of allergy and clinical immunology.
[19] Reto Stöcklin,et al. Anti‐microbial peptides: from invertebrates to vertebrates , 2004, Immunological reviews.
[20] T. Nürnberger,et al. Innate immunity in plants and animals: emerging parallels between the recognition of general elicitors and pathogen-associated molecular patterns. , 2002, Current opinion in plant biology.
[21] D. Andreu,et al. Animal antimicrobial peptides: an overview. , 1998, Biopolymers.
[22] H. Nikaido. Molecular Basis of Bacterial Outer Membrane Permeability Revisited , 2003, Microbiology and Molecular Biology Reviews.
[23] Y. Shai,et al. Endotoxin (Lipopolysaccharide) Neutralization by Innate Immunity Host-Defense Peptides , 2006, Journal of Biological Chemistry.
[24] A. Vitiello,et al. Cutting Edge: Mast Cell Antimicrobial Activity Is Mediated by Expression of Cathelicidin Antimicrobial Peptide 1 , 2003, The Journal of Immunology.
[25] K. Dyer,et al. The RNase a superfamily: Generation of diversity and innate host defense , 2006, Molecular Diversity.
[26] M. Bertoldi,et al. Structural versatility of bovine ribonuclease A. Distinct conformers of trimeric and tetrameric aggregates of the enzyme. , 1999, European journal of biochemistry.
[27] E. Boix,et al. Kinetic and Product Distribution Analysis of Human Eosinophil Cationic Protein Indicates a Subsite Arrangement That Favors Exonuclease-type Activity* , 1999, The Journal of Biological Chemistry.
[28] T. Beveridge,et al. Structural differentiation of the Bacillus subtilis 168 cell wall , 1994, Journal of bacteriology.
[29] R. Prill,et al. Engineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction , 1999, Nature Biotechnology.
[30] D. Philpott,et al. Mini‐review: The role of peptidoglycan recognition in innate immunity , 2004, European journal of immunology.
[31] A. Ouellette,et al. Activation of Paneth Cell α-Defensins in Mouse Small Intestine* , 2002, The Journal of Biological Chemistry.
[32] Y. Shai,et al. Mode of action of linear amphipathic α-helical antimicrobial peptides , 1998 .
[33] M. Koch,et al. Biophysical characterisation of lysozyme binding to LPS Re and lipid A. , 1998, European journal of biochemistry.
[34] T. Pufe,et al. Expression and regulation of antimicrobial peptides in articular joints. , 2005, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.
[35] L. Beamer. Structure of human BPI (bactericidal/permeability-increasing protein) and implications for related proteins. , 2003, Biochemical Society transactions.
[36] P. Jollès,et al. What's new in lysozyme research? , 1984, Molecular and Cellular Biochemistry.
[37] O. Levy,et al. Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. , 2000, Blood.
[38] Tomohiro Watanabe,et al. Signalling pathways and molecular interactions of NOD1 and NOD2 , 2006, Nature Reviews Immunology.
[39] C. Glabe. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease , 2006, Neurobiology of Aging.
[40] D Eisenberg,et al. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. , 1997, Science.
[41] R. Dziarski,et al. Peptidoglycan recognition in innate immunity. , 2005, Journal of endotoxin research.
[42] Y. Shai,et al. Host defense peptides as new weapons in cancer treatment , 2005, Cellular and Molecular Life Sciences CMLS.
[43] D Eisenberg,et al. The BPI/LBP family of proteins: A structural analysis of conserved regions , 1998, Protein science : a publication of the Protein Society.
[44] K. Dyer,et al. Gene structure and enzymatic activity of mouse eosinophil-associated ribonuclease 2. , 2001, Gene.
[45] K. Dyer,et al. Evolution and Function of Leukocyte RNase A Ribonucleases of the Avian Species, Gallus gallus* , 2006, Journal of Biological Chemistry.
[46] J. Heckels,et al. Molecular arrangement of teichoic acid in the cell wall of Staphylococcus lactis. , 1973, Nature: New biology.
[47] Susanna Navarro,et al. Topography studies on the membrane interaction mechanism of the eosinophil cationic protein. , 2007, Biochemistry.
[48] K. Dyer,et al. Rapid evolution of a unique family of primate ribonuclease genes , 1995, Nature Genetics.
[49] M. V. Nogués,et al. Surface-exposed amino acids of eosinophil cationic protein play a critical role in the inhibition of mammalian cell proliferation , 2005, Molecular and Cellular Biochemistry.
[50] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[51] J. Gavilanes,et al. Bovine seminal ribonuclease destabilizes negatively charged membranes. , 1994, Biochemical and biophysical research communications.
[52] H. Sticht,et al. Structure determination of human and murine β‐defensins reveals structural conservation in the absence of significant sequence similarity , 2001, Protein science : a publication of the Protein Society.
[53] Ziheng Yang,et al. A Maximum Likelihood Method for Detecting Functional Divergence at Individual Codon Sites, with Application to Gene Family Evolution , 2004, Journal of Molecular Evolution.
[54] Jianzhi Zhang,et al. Rapid Evolution of the Ribonuclease A Superfamily: Adaptive Expansion of Independent Gene Clusters in Rats and Mice , 1999, Journal of Molecular Evolution.
[55] S. Ehlers,et al. Tertiary Structure of Bacterial Murein: the Scaffold Model , 2003, Journal of bacteriology.
[56] S. Ehlers,et al. Tertiary Structure of Staphylococcus aureus Cell Wall Murein , 2004, Journal of bacteriology.
[57] Kai Hilpert,et al. High-throughput generation of small antibacterial peptides with improved activity , 2005, Nature Biotechnology.
[58] M. Nakajima,et al. Expression and Purification of Recombinant Rat Eosinophil-Associated Ribonucleases, Homologues of Human Eosinophil Cationic Protein and Eosinophil-Derived Neurotoxin, and Their Characterization , 2001, International Archives of Allergy and Immunology.
[59] K. Dyer,et al. Molecular cloning of four novel murine ribonuclease genes: unusual expansion within the ribonuclease A gene family. , 1997, Nucleic acids research.
[60] R. Hancock,et al. The relationship between peptide structure and antibacterial activity , 2003, Peptides.
[61] C. Zipfel,et al. Plants and animals: a different taste for microbes? , 2005, Current opinion in plant biology.
[62] Robert E W Hancock,et al. Role of membranes in the activities of antimicrobial cationic peptides. , 2002, FEMS microbiology letters.
[63] Domenico Romeo,et al. Cathelicidins: a novel protein family with a common proregion and a variable C‐terminal antimicrobial domain , 1995, FEBS letters.
[64] Klaus Düring,et al. The non‐enzymatic microbicidal activity of lysozymes , 1999, FEBS letters.
[65] F. G. Prendergast,et al. Interaction of eosinophil granule major basic protein with synthetic lipid bilayers: A mechanism for toxicity , 1992, The Journal of Membrane Biology.
[66] J. Schröder,et al. RNase 7, a Novel Innate Immune Defense Antimicrobial Protein of Healthy Human Skin* , 2002, The Journal of Biological Chemistry.
[67] Chow H Lee,et al. Destroying RNA as a therapeutic approach. , 2006, Current medicinal chemistry.
[68] J. Schröder,et al. Antimicrobial peptides in human skin. , 2005, Chemical immunology and allergy.
[69] A. Glynn,et al. Lysozyme and Immune Bacteriolysis , 1965, Nature.
[70] S. Orkin,et al. A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.
[71] S. Weinkauf,et al. Ultrastructural characterization of peptide-induced membrane fusion and peptide self-assembly in the lipid bilayer. , 1999, Biophysical journal.
[72] K. Fredens,et al. Eosinophil Activation in Ulcerative Colitis (Studies on Mucosal Release and Localization of Eosinophil Granule Constituents) , 1998, Digestive Diseases and Sciences.
[73] P. Venge,et al. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion , 1999, American Journal of Gastroenterology.
[74] E. Boix,et al. Crystal structure of eosinophil cationic protein at 2.4 A resolution. , 1999, Biochemistry.
[75] P. Elsbach,et al. Role of the bactericidal/permeability-increasing protein in host defence. , 1998, Current opinion in immunology.
[76] D. Newton,et al. Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma. , 2001, Blood.
[77] H. Rosenberg. Recombinant Human Eosinophil Cationic Protein , 1995, The Journal of Biological Chemistry.
[78] K. Ohuchi,et al. Identification of cDNA for Rat Homologues of Human Major Basic Protein and Eosinophil Cationic Protein , 1998, International Archives of Allergy and Immunology.
[79] G. H. Gudmundsson,et al. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. , 1999, Journal of immunological methods.
[80] J. Pous,et al. Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution. , 2000, Journal of molecular biology.
[81] K. Diederichs,et al. A conserved structural motif for lipopolysaccharide recognition by procaryotic and eucaryotic proteins. , 2000, Structure.
[82] Jonathan Cohen. The immunopathogenesis of sepsis , 2002, Nature.
[83] R. Hancock,et al. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.
[84] Jianzhi Zhang,et al. Evolution of the rodent eosinophil-associated RNase gene family by rapid gene sorting and positive selection. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[85] James J. Lee,et al. Mouse eosinophil-associated ribonucleases: a unique subfamily expressed during hematopoiesis , 2001, Mammalian Genome.
[86] B. Niggemann,et al. In vitro release of eosinophil cationic protein from peripheral eosinophils reflects disease activity in childhood Crohn disease and ulcerative colitis , 1997, European Journal of Pediatrics.
[87] K. Dyer,et al. Ribonucleases and host defense: identification, localization and gene expression in adherent monocytes in vitro. , 1997, Biochimica et biophysica acta.
[88] P. Venge,et al. Mechanism of membrane damage mediated by human eosinophil cationic protein , 1986, Nature.
[89] Y. Shai,et al. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. , 1999, Biochimica et biophysica acta.
[90] T. Ganz,et al. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. , 1989, Journal of immunology.
[91] D. Loegering,et al. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. , 1989, The American review of respiratory disease.
[92] K. Matsuzaki. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. , 1999, Biochimica et biophysica acta.
[93] S. White,et al. Interactions between human defensins and lipid bilayers: Evidence for formation of multimeric pores , 1994, Protein science : a publication of the Protein Society.
[94] S. Rybak,et al. Humanization of immunotoxins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[95] R. Dahl,et al. Extracellular deposit of the cationic proteins ECP and EPX in tissue infiltrations of eosinophils related to tissue damage , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[96] Ron D. Appel,et al. ExPASy: the proteomics server for in-depth protein knowledge and analysis , 2003, Nucleic Acids Res..
[97] D. Fischer,et al. Detecting distant relatives of mammalian LPS‐binding and lipid transport proteins , 1998, Protein science : a publication of the Protein Society.
[98] Patrice Gouet,et al. ESPript: analysis of multiple sequence alignments in PostScript , 1999, Bioinform..
[99] E. Boix,et al. Eosinophil cationic protein. , 2001, Methods in enzymology.
[100] Robert E. W. Hancock,et al. Structure and Association of Human Lactoferrin Peptides with Escherichia coli Lipopolysaccharide , 2004, Antimicrobial Agents and Chemotherapy.
[101] K. Diederichs,et al. Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. , 1998, Science.
[102] Jianzhi Zhang,et al. The ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories. , 2005, Genomics.
[103] M. Nakajima,et al. Preparation of recombinant rat eosinophil-associated ribonuclease-1 and -2 and analysis of their biological activities. , 2003, Biochimica et biophysica acta.
[104] Jianzhi Zhang,et al. RNase 8, a novel RNase A superfamily ribonuclease expressed uniquely in placenta. , 2002, Nucleic acids research.
[105] Niv Papo,et al. Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes? , 2003, Peptides.
[106] J. Dubois,et al. Molecular evolution of mammalian ribonucleases 1. , 2003, Molecular phylogenetics and evolution.
[107] K. Acharya,et al. Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth. , 1999, Journal of molecular biology.
[108] N. Krug,et al. Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma. , 2004, The Journal of allergy and clinical immunology.
[109] D. Philpott,et al. Recognition of Staphylococcus aureus by the Innate Immune System , 2005, Clinical Microbiology Reviews.
[110] T. Koob,et al. N- and O-Linked Keratan Sulfate on the Hyaluronan Binding Region of Aggrecan from Mature and Immature Bovine Cartilage (*) , 1995, The Journal of Biological Chemistry.
[111] N. Pavlakis,et al. Ranpirnase – an antitumour ribonuclease: its potential role in malignant mesothelioma , 2006, Expert opinion on biological therapy.
[112] I. Hirata,et al. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease , 1999, American Journal of Gastroenterology.
[113] J. Gesell,et al. Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an α-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution , 1997, Journal of biomolecular NMR.
[114] D. Eisenberg,et al. Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. , 1996, Chemistry & biology.
[115] D. Hughes,et al. Sampling the Antibiotic Resistome , 2006, Science.
[116] E. Pauwels,et al. Human Lactoferrin and Peptides Derived from Its N Terminus Are Highly Effective against Infections with Antibiotic-Resistant Bacteria , 2001, Infection and Immunity.
[117] S. Rybak,et al. Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition , 2003, AIDS.
[118] K. Ohuchi,et al. Identification of cDNA encoding rat eosinophil cationic protein/eosinophil-associated ribonuclease. , 1997, Biochimica et biophysica acta.
[119] Shih-Hsiung Wu,et al. The Flexible and Clustered Lysine Residues of Human Ribonuclease 7 Are Critical for Membrane Permeability and Antimicrobial Activity* , 2007, Journal of Biological Chemistry.
[120] M Ptak,et al. Refined three-dimensional solution structure of insect defensin A. , 1995, Structure.
[121] S. Verselis,et al. Angiogenin is regulated in vivo as an acute phase protein. , 1998, Biochemical and biophysical research communications.
[122] K. Dyer,et al. Evolution of antiviral activity in the ribonuclease A gene superfamily: evidence for a specific interaction between eosinophil-derived neurotoxin (EDN/RNase 2) and respiratory syncytial virus. , 1998, Nucleic acids research.
[123] D. Sidransky,et al. Ribonucleases as a Novel Pro-Apoptotic Anticancer Strategy: Review of the Preclinical and Clinical Data for Ranpirnase , 2005, Cancer investigation.
[124] Y. Raab,et al. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease , 2002, American Journal of Gastroenterology.
[125] K. Amako,et al. Distribution of capsular materials on the cell wall surface of strain Smith diffuse of Staphylococcus aureus , 1991, Journal of bacteriology.
[126] R. Ellison,et al. Killing of gram-negative bacteria by lactoferrin and lysozyme. , 1991, The Journal of clinical investigation.
[127] T. Yip,et al. Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. , 1998, Biochimica et biophysica acta.
[128] M. Moenner,et al. The widespread expression of angiogenin in different human cells suggests a biological function not only related to angiogenesis. , 1994, European journal of biochemistry.
[129] S. Blondelle,et al. Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics. , 2005, Combinatorial chemistry & high throughput screening.
[130] K. Dyer,et al. Eosinophil Cationic Protein and Eosinophil-derived Neurotoxin , 1995, Journal of Biological Chemistry.
[131] I. Ginsburg. Bactericidal cationic peptides can also function as bacteriolysis-inducing agents mimicking beta-lactam antibiotics?; it is enigmatic why this concept is consistently disregarded. , 2004, Medical hypotheses.
[132] M. Caroff,et al. Structure of bacterial lipopolysaccharides. , 2003, Carbohydrate research.
[133] Ester Boix,et al. Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein. , 2003, Biochemistry.
[134] I. Autenrieth,et al. Intestinal epithelial barrier and mucosal immunity , 2005, Cellular and Molecular Life Sciences.
[135] G. Gotte,et al. Thermal Aggregation of Ribonuclease A , 2003, The Journal of Biological Chemistry.
[136] J. Gabay,et al. Antibiotic peptides and serine protease homologs in human polymorphonuclear leukocytes: defensins and azurocidin. , 1993, Current opinion in immunology.
[137] R. Locksley,et al. The Instructive Role of Innate Immunity in the Acquired Immune Response , 1996, Science.
[138] D. Eisenberg,et al. The three-dimensional structure of human bactericidal/permeability-increasing protein: implications for understanding protein-lipopolysaccharide interactions. , 1999, Biochemical pharmacology.